Associations between Physical Exercise, Quality of Life, Psychological Symptoms and Treatment Side Effects in Early Breast Cancer
Authors:
- Leena VehmanenLVLeena Vehmanen
- Johanna MattsonJMJohanna Mattson
- Evangelos KarademasEKEvangelos Karademas
- Albino J. Oliveira-MaiaAOAlbino J. Oliveira-Maia
- Berta SousaBSBerta Sousa
- Ruth Pat-HorenczykRPRuth Pat-Horenczyk
- Ketti MazzoccoKMKetti Mazzocco
- Panagiotis SimosPSPanagiotis Simos
- Fátima CardosoFCFátima Cardoso
- Greta PettiniGPGreta Pettini
- Chiara MarzoratiCMChiara Marzorati
- Eleni KolokotroniEKEleni Kolokotroni
Open Access
- 19 November 2022
- journal article
- research article
- Published by Wiley in The Breast Journal
- Vol. 2022, 1-8
Abstract
Background. Identifying and understanding modifiable factors for the well-being of cancer patients is critical in survivorship research. We studied variables associated with the exercise habits of breast cancer patients and investigated if the achievement of exercise recommendations was associated with enhanced quality of life and/or psychological well-being. Material and Methods. 311 women from Finland, Portugal, Israel, and Italy receiving adjuvant therapy for stage I–III breast cancer answered questions about sociodemographic factors and physical exercise. Quality of life was assessed by the EORTC C30 and BR23 questionnaires. Anxiety and depression were evaluated using the HADS scale. Results. At the beginning of adjuvant therapy and after twelve months, 32% and 26% of participants were physically inactive, 27% and 30% exercised between 30 and 150 minutes per week, while 41% and 45% exercised the recommended 150 minutes or more per week. Relative to other countries, Finnish participants were more likely to be active at baseline and at twelve months (89% vs. 50%, and 87% vs. 64%, ). Participants with stage I cancer were more likely to be active at twelve months than those with a higher stage (80% vs. 70%, ). The inactive participants reported more anxiety ( ) and depression ( ), lower global quality of life ( ), and more side effects ( ) than the others at twelve months. Accordingly, those who remained inactive or decreased their level of exercise from baseline to twelve months reported more anxiety ( ) and depression ( ), lower global quality of life ( ), and more side effects ( ) than those with the same or increased level of exercise. Conclusion. For women with early breast cancer, exercise was associated with a better quality of life, less depression and anxiety, and fewer adverse events of adjuvant therapy. Trial registration number: NCT05095675. Paula Poikonen-Saksela on behalf of Bounce consortium (https://www.bounce-project.eu/).Keywords
Funding Information
- European Union’s Horizon 2020 Research and Innovation Programme (777167)
This publication has 32 references indexed in Scilit:
- Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studiesActa Oncologica, 2015
- Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trialInternational Journal of Cancer, 2014
- Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysisAnnals of Oncology, 2014
- The Efficacy of Exercise in Reducing Depressive Symptoms among Cancer Survivors: A Meta-AnalysisPLOS ONE, 2012
- Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health‐related quality of life in breast cancer patients and survivors—a meta‐analysisPsycho-Oncology, 2011
- Exercise Interventions for Cancer Survivors: A Meta-Analysis of Quality of Life OutcomesAnnals of Behavioral Medicine, 2010
- American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer SurvivorsMedicine & Science in Sports & Exercise, 2010
- Physical activity levels before and after a diagnosis of breast carcinomaCancer, 2003
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983